AB0985 Methotrexate as induction of remission therapy for localized manifestations of IGG4-related disease

Published: Jun 1, 2017
Abstract
Background null Medium to high dose glucocorticoids represents the treatment of choice for inducing remission in IgG4-related disease (IgG4-RD) patients1. However, clinicians might prefer alternative equally effective drugs in clinical settings where long-term corticosteroids treatment is contraindicated, such as diabetes or osteoporosis. We recently reported the efficacy of methotrexate in maintaining glucocorticoids induced IgG4-RD remission2....
Paper Details
Title
AB0985 Methotrexate as induction of remission therapy for localized manifestations of IGG4-related disease
Published Date
Jun 1, 2017
Journal
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.